| HOME >> BIOLOGY >> TECHNOLOGY |
Cost of revenue
System 2,954,061 5,011,858 10,978,108 10,448,772
Disposables,
service and
accessories 764,897 790,953 2,497,459 2,443,977
Inventory
impairment - - 1,870,653 -
Total cost of
revenue 3,718,958 5,802,811 15,346,220 12,892,749
Gross margin 6,535,905 8,202,769 23,952,589 14,298,957
Operating expenses:
Research and
development 5,996,138 4,547,773 25,471,809 21,794,177
General and
administration 4,589,694 4,071,212 18,701,726 16,642,359
Sales and marketing 8,287,708 6,086,065 29,021,117 22,533,882
Total operating
expenses 18,873,540 14,705,050 73,194,652 60,970,418
Operating loss (12,337,635) (6,502,281) (49,242,063) (46,671,461)
Interest income 258,859 488,344 1,471,503 2,126,987
Interest expense (134,455) (146,425) (350,954) (1,175,296)
Net loss $(12,213,231) $(6,160,362) $(48,121,514) $(45,719,770)
Net loss per common
share:
Basic and diluted $(0.34) $(0.18) $(1.34) $(1.39)
Weighted average
shares used in
computing net loss
per common share:
Basic and diluted 36,331,376 33,985,126 35,793,973 32,979,403
STEREOTAXIS, INC.
BALANCE SHEETS
December 31, December 31,
2007 2006
(Unaudited)
Assets
Current Assets:
Cash and cash equivalents
'/>"/>
| SOURCE Stereotaxis, Inc. Copyright©2008 PR Newswire. All rights reserved |